Heart confidence after pulmonary hypertension surgery
Part of Heart & circulation, Lungs & breathing clinical trials.
This study looks at how confident patients feel about managing their heart health after surgery for chronic thromboembolic pulmonary hypertension. It may help doctors understand how to better support recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be scheduled for or have had surgery called pulmonary thromboendarterectomy for CTEPH.
- You must be able to read and understand consent forms and questionnaires.
- You should not be having balloon pulmonary angioplasty or taking only medicines for your condition.
- Your surgery should not be an emergency case.
- You must not have severe memory or thinking problems, mental illness, or a language barrier that prevents filling out forms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a small implanted sensor (CardioMEMS) that monitors pressure in the lung artery can help doctors detect and manage complications after surgery for chronic blood clots in the lungs. It aims to improve recovery and long-term outcomes.
This study looks at patterns from specialized lung scan tests to help diagnose chronic thromboembolic pulmonary hypertension (a long-term problem with blood flow in the lungs after blood clots). If your results suggest this condition and you need a procedure to check heart pressure, you may be asked to join so the researchers can improve diagnosis.
This trial tests whether a procedure called balloon pulmonary angioplasty is safe and effective for people with chronic thromboembolic disease in the lungs, especially when surgery isn’t an option. If you have CTEPH, it may help improve lung blood flow and symptoms.
This study compares balloon pulmonary angioplasty versus pulmonary endarterectomy for people with chronic thromboembolic pulmonary hypertension (high blood pressure in the lungs due to long-lasting blood clots). It may help find which procedure works better for improving symptoms and lung circulation after treatment.
This trial is for people with a type of long-term blood clot in the lungs (CTEPH) who have been taking riociguat for at least 12 weeks. It will see what happens when the medication is stopped, focusing on how the right side of the heart is doing.
This study helps doctors update and improve how they understand chronic thromboembolic pulmonary hypertension (CTEPH) in patients in China. It likely involves sharing your medical information (not a new drug) and confirming your diagnosis details to support future research.
Hear when a new Chronic Thromboembolic Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.